Grau-Vorster, M.; RodrĂguez, L.; del Mazo-Barbara, A.; Mirabel, C.; Blanco, M.; Codinach, M.; GĂłmez, S.G.; Querol, S.; GarcĂa-LĂłpez, J.; Vives, J.
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly. Cells 2019, 8, 484.
https://doi.org/10.3390/cells8050484
AMA Style
Grau-Vorster M, RodrĂguez L, del Mazo-Barbara A, Mirabel C, Blanco M, Codinach M, GĂłmez SG, Querol S, GarcĂa-LĂłpez J, Vives J.
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly. Cells. 2019; 8(5):484.
https://doi.org/10.3390/cells8050484
Chicago/Turabian Style
Grau-Vorster, Marta, Luciano RodrĂguez, Anna del Mazo-Barbara, ClĂ©mentine Mirabel, Margarita Blanco, Margarita Codinach, Susana G. GĂłmez, Sergi Querol, Joan GarcĂa-LĂłpez, and Joaquim Vives.
2019. "Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly" Cells 8, no. 5: 484.
https://doi.org/10.3390/cells8050484
APA Style
Grau-Vorster, M., RodrĂguez, L., del Mazo-Barbara, A., Mirabel, C., Blanco, M., Codinach, M., GĂłmez, S. G., Querol, S., GarcĂa-LĂłpez, J., & Vives, J.
(2019). Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly. Cells, 8(5), 484.
https://doi.org/10.3390/cells8050484